Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 4 minute read Pharma Industry News Japan approves Minjuvi for relapsed follicular lymphoma: What does this dual-CD immunotherapy mean for the market? Incyte’s Minjuvi gets Japan approval for relapsed FL. Find out how this dual-CD regimen is reshaping immunotherapy options in a high-need market. byPallavi MadhirajuJanuary 5, 2026